CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

November 9, 2022 · earnings

CLDX earnings: a negative outcome, -5.7%

On November 9, 2022, Celldex Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -5.7% in the window around the event. It had already run +19.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$34.55
1d before
$32.59
Event day
$37.80
1d after
$36.50
5d after

Pre-catalyst setup

+19.7%
30-day run-up
4434%
30-day volatility
1.1×
volume spike